|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | |
| C07D 403/06 | |||
| C07D 405/14 | |||
| A61K 31/454 | |||
| A61K 31/496 | |||
| A61P 3/00 |
| (11) | Number of the document | 2010519 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07755189.3 |
| Date of filing the European patent application | 2007-04-10 | |
| (97) | Date of publication of the European application | 2009-01-07 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/008832 |
| Date | 2007-04-10 |
| (87) | Number | WO 2007/120655 |
| Date | 2007-10-25 |
| (30) | Number | Date | Country code |
| 791961 P | 2006-04-14 | US |
| (72) |
BERGER, Richard, US
EDMONDSON, Scott, US
HANSEN, Alexa, US
ZHU, Cheng, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS |
| SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS |